FDA can do more to ensure diversity in clinical trials, experts say — including some constructive badgering

The Covid-19 vaccine and therapeutic development races have opened many eyes to the reality that clinical trials in the US rarely include the appropriate numbers of ethnic and racial minorities. And even when they sometimes get close, as with Moderna’s vaccine, the trial had to be deliberately slowed to recruit...

Click to view original post